1.2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS)
Chan Ho LEE ; Minyong KANG ; Cheol KWAK ; Sung Han KIM ; Jung Kwon KIM ; Jae Young PARK ; Seong Il SEO ; Ill Young SEO ; Jungyo SUH ; Wan SONG ; Cheryn SONG ; Hyeong Dong YUK ; Sangchul LEE ; Hyung Ho LEE ; Jinsoo CHUNG ; Chang Wook JEONG ; Jung Ki JO ; Chang Il CHOI ; Seol Ho CHOO ; Jun Hyun HAN ; Eu Chang HWANG ; Miso KIM ; Chan KIM ; Seock Hwan CHOI ; Sung-Hoo HONG
Korean Journal of Urological Oncology 2022;20(3):151-162
Purpose:
The Korean Renal Cancer Study Group (KRoCS) provides consensus recommendations on the role of cytoreductive nephrectomy (CRN) in patients with metastatic renal cell carcinoma (mRCC).
Materials and Methods:
A group of mRCC experts from the Korean Urological Oncology Society convened at the 2021 KRoCS meeting on CRN for mRCC.
Results:
The consensus document was developed to address 4 questions related that were judged to be the most relevant to patient care: (1) Is there a role for CRN in patients planning targeted therapy? (2) Is there a role for CRN in patients planning immuno-oncology agents? (3) When is the optimal time of CRN in patients planning systemic treatment? (4) What is the ideal patient selection for CRN? The panelists have come up with following consensus. For mRCC patients, CRN should be considered only in those with IMDC (International Metastatic Renal Cell Carcinoma Database Consortium) favorable and intermediate risk disease, regardless of the systemic treatment plans. Timing of CRN should consider the risk group as well as the number of risk factors, but is generally recommended for after assessing the degree of response to initial systemic treatment. Patients with good performance status, limited metastatic burden on top of resectable primary tumor are candidates recommended for CRN with or without metastasectomy with priority.
Conclusions
In conclusion, there is still a role for CRN in the multimodality treatment of mRCC. Careful patient selection is of paramount importance. As the treatment landscape of mRCC continues to change, the role of CRN in the current immuno-oncology era will require more exploration.
2.Cytological endometritis in dairy cows: diagnostic threshold, risk factors, and impact on reproductive performance
Soo Chan LEE ; Jae Kwan JEONG ; In Soo CHOI ; Hyun Gu KANG ; Young Hun JUNG ; Soo Bong PARK ; Ill Hwa KIM
Journal of Veterinary Science 2018;19(2):301-308
We determined the threshold proportion of polymorphonuclear leukocytes (PMNs) for a diagnosis of cytological endometritis (CEM), the risk factors for this condition, and its impact on reproductive performance in dairy cows. Uterine cytology was performed on 407 Holstein cows 4 weeks postpartum to determine the proportions of endometrial cells and PMNs. A receiver operator characteristics curve was used to determine the threshold above which the PMN proportion affected the likelihood of cows conceiving by 200 days postpartum. The optimal threshold was ≥ 14% PMN (sensitivity, 31.3%; specificity, 81.7%; p < 0.05). The farm identity, retained placenta (odds ratio [OR] = 1.87), and septicemic metritis (OR = 3.07) were risk factors for CEM (p < 0.05). Cows with CEM were less likely to resume cyclicity (OR = 0.58) and to conceive by 200 days postpartum (hazard ratio = 0.58). Cows with CEM tended (p < 0.1) to be less likely to become pregnant after their first insemination (OR = 0.65) and to require a greater number of inseminations per conception (2.3 vs. 2.2). In conclusion, a PMN threshold of 14% defined the presence of CEM at 4 weeks postpartum. The farm, retained placenta, and septicemic metritis were risk factors for CEM, which reduces subsequent reproductive performance.
Agriculture
;
Diagnosis
;
Endometritis
;
Female
;
Fertilization
;
Insemination
;
Neutrophils
;
Periodicity
;
Placenta, Retained
;
Postpartum Period
;
Risk Factors
;
Sensitivity and Specificity
3.Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
Hyojung PARK ; Dongryul OH ; Yong Chan AHN ; Hongryull PYO ; Jae Myung NOH ; Jong Mu SUN ; Jin Seok AHN ; Myung Ju AHN ; Keunchil PARK ; Hong Kwan KIM ; Yong Soo CHOI ; Jhingook KIM ; Jae Ill ZO ; Young Mog SHIM
Cancer Research and Treatment 2017;49(4):880-889
PURPOSE: The optimal adjuvant therapy modality for treating pN2 non-small cell lung cancer patients has not yet been established. In this study, the authors investigated clinical outcomes following three different adjuvant therapy modalities. MATERIALS AND METHODS: From January 2006 to December 2012, 240 patients with cN0/1 disease were found to have pN2 disease following curative resection and received one of three adjuvant therapy modalities:thoracic radiation therapy (TRT) and concurrent chemotherapy (CTx) (CCRT) (group I), CCRT plus consolidation CTx (group II), and CTx alone (group III). TRT was delivered to 155 patients (groups I/II), and full dose CTx was delivered to 172 patients either as a consolidative or a sole modality (group II/III). RESULTS: During 30 months of median follow-up, 44 patients died and 141 developed recurrence. The 5-year overall survival (OS), locoregional control (LRC), distant metastasis-free survival (DMFS), and disease-free survival (DFS) rates of all patients were 76.2%, 80.7%, 36.4%, and 29.6%, respectively. There was no difference in OS among groups. TRT (groups I/II) significantly improved LRC, full dose CTx (groups II/III) did DMFS, and CCRT plus consolidation CTx (group II) did DFS, respectively. CONCLUSION: The current study could support that TRT could improve LRC and full dose CTx could improve DMFS and that CCRT plus consolidation CTx could improve DFS.
Carcinoma, Non-Small-Cell Lung*
;
Chemotherapy, Adjuvant
;
Disease-Free Survival
;
Drug Therapy*
;
Follow-Up Studies
;
Humans
;
Radiotherapy
;
Recurrence
4.A Case of Pancreatic Metastasis From a Papillary Thyroid Carcinoma Mimicking Pancreatic Cancer.
Ji Hoon LEE ; Dong Ki LEE ; Sung Ill JANG ; Hong Kyu CHOI ; Chan Ik PARK ; Ji Eun YUN ; Soon Won HONG
Korean Journal of Medicine 2014;87(2):187-192
Papillary thyroid cancer (PTC) has a good prognosis and a low incidence of distant metastases. It is extremely rare for PTC to metastasize to the pancreas. Only five cases have been previously reported worldwide. Most cases are discovered incidentally by abdominal computed tomography (CT) or positron emission tomography-CT (PET-CT) during follow-up studies after thyroidectomies. Pancreatic metastasis of PTC is usually unidentifiable by a whole-body I131 scan, a common follow-up modality. When a pancreatic mass is found in patients with PTC, it must be differentiated from pancreatic cancer. In previous reports, patients with pancreatic metastases of PTC underwent operations for therapeutic diagnosis or underwent fine needle aspiration biopsies (FNAB). However, it is unclear whether the benefit of an operation outweighs the risk. We experienced a case of PTC with pancreatic metastasis that was found on PET-CT. Contrast-enhanced endoscopic ultrasonography (EUS) was performed to evaluate the characteristics of the pancreatic mass and pathological confirmation was obtained cytologically via EUS-FNA.
Biopsy
;
Biopsy, Fine-Needle
;
Diagnosis
;
Electrons
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration
;
Endosonography
;
Follow-Up Studies
;
Humans
;
Incidence
;
Neoplasm Metastasis*
;
Pancreas
;
Pancreatic Neoplasms*
;
Prognosis
;
Thyroid Neoplasms*
;
Thyroidectomy
5.Mechanism of Relaxation Via TASK-2 Channels in Uterine Circular Muscle of Mouse.
Seung Hwa HONG ; Rohyun SUNG ; Young Chul KIM ; Hikaru SUZUKI ; Woong CHOI ; Yeon Jin PARK ; Ill Woon JI ; Chan Hyung KIM ; Sun Chul MYUNG ; Moo Yeol LEE ; Tong Mook KANG ; Ra Young YOU ; Kwang Ju LEE ; Seung Woon LIM ; Hyo Yung YUN ; Young Jin SONG ; Wen Xie XU ; Hak Soon KIM ; Sang Jin LEE
The Korean Journal of Physiology and Pharmacology 2013;17(4):359-365
Plasma pH can be altered during pregnancy and at labor. Membrane excitability of smooth muscle including uterine muscle is suppressed by the activation of K+ channels. Because contractility of uterine muscle is regulated by extracellular pH and humoral factors, K+ conductance could be connected to factors regulating uterine contractility during pregnancy. Here, we showed that TASK-2 inhibitors such as quinidine, lidocaine, and extracellular acidosis produced contraction in uterine circular muscle of mouse. Furthermore, contractility was significantly increased in pregnant uterine circular muscle than that of non-pregnant muscle. These patterns were not changed even in the presence of tetraetylammonium (TEA) and 4-aminopyridine (4-AP). Finally, TASK-2 inhibitors induced strong myometrial contraction even in the presence of L-methionine, a known inhibitor of stretchactivated channels in myometrium. When compared to non-pregnant myometrium, pregnant myometrium showed increased immunohistochemical expression of TASK-2. Therefore, TASK-2, seems to play a key role during regulation of myometrial contractility in the pregnancy and provides new insight into preventing preterm delivery.
4-Aminopyridine
;
Acidosis
;
Animals
;
Contracts
;
Female
;
Hydrogen-Ion Concentration
;
Lidocaine
;
Membranes
;
Methionine
;
Mice
;
Muscle, Smooth
;
Muscles
;
Myometrium
;
Plasma
;
Pregnancy
;
Quinidine
;
Relaxation
;
Uterine Contraction
;
Uterus
6.The Results of Nation-Wide Registry of Age-related Macular Degeneration in Korea.
Kyu Hyung PARK ; Su Jeong SONG ; Won Ki LEE ; Hee Sung YOON ; Hyoung Jun KOH ; Chul Gu KIM ; Yun Young KIM ; Se Woong KANG ; Ha Kyoung KIM ; Byung Ro LEE ; Dong Heun NAM ; Pill Young LEE ; Hyoung Su KIM ; Hyeoung Chan KIM ; Si Yeol KIM ; In Young KIM ; Gwang Su KIM ; Kuhl HUH ; Jae Ryung OH ; Shin Dong KIM ; Sang Jun LEE ; Young Duk KIM ; Soon Hyun KIM ; Tae Gon LEE ; Sung Won JOE ; Dong Cho LEE ; Mu Hwan CHANG ; Si Dong KIM ; Young Wok JOE ; Sun Ryang BAE ; Ju Eun LEE ; Boo Sup OUM ; Ill Han YOON ; Soon Ill KWON ; Jae Hoon KANG ; Jong In KIM ; Sang Woong MOON ; Hyeong Gon YU ; Young Hee YOON ; Gwang Yul CHANG ; Sung Chul LEE ; Sung Jin LEE ; Tae Kwan PARK ; Young Hun OHN ; Oh Woong KWON ; Woo Hyok CHANG ; Yeon Sik YANG ; Suk Jun LEE ; Su Young LEE ; Chang Ryong KIM ; Jung Hee LEE ; Yeon Sung MOON ; Jae Kyoun AHN ; Nam Chun JOE ; Gwang Ju CHOI ; Young Joon JOE ; Sang Kook KIM ; Sung Pyo PARK ; Woo Hoo NAM ; Hee Yoon JOE ; Jun Hyun KIM ; Hum CHUNG
Journal of the Korean Ophthalmological Society 2010;51(4):516-523
PURPOSE: To evaluate the incidence and clinical features of age-related macular degeneration (AMD) in Korea. METHODS: Web-based (www.armd-nova.or.kr) registration was conducted for AMD patients aged 50 or more who were newly diagnosed by retinal specialists in Korea from August 20, 2005 to August 20, 2006. Patient data including ophthalmologic examination, fundus photography, fluorescein angiogram and/or indocyanin green angiogram (ICG), past medical history, behavioral habit, combined systemic diseases were up-loaded. RESULTS: Among finally enrolled 1,141 newly diagnosed AMD patients, 690 patients (60.5%) were male and 451 patients (39.5%) were female. The average age of AMD patients was 69.7+/-8.0. Early AMD was observed in 190 patients and 951 patients had late AMD. Classic choroidal neovascular membrane (CNVM) was observed in 18.6% of exudative AMD patients and 63.4 % had occult CNVM. Subfoveal CNVM was observed in 80.4% of the patients with CNVM. Among the 580 exudative AMD eyes that performed indocyanin green angiography (ICG), 184 eyes (31.7%) had polypoidal choroidal vasculopathy (PCV) and 36 eyes (6.2%) showed retinal angiomatous proliferation (RAP). Age, male gender, smoking, diabetes and hypertension significantly increased the risk of the AMD among Koreans. CONCLUSIONS: Because of the low rate of participation by retinal specialists, definite incidence of AMD was not obtainable. However, the estimated 1-year AMD incidence in the Pusan area of Korea is at least 0.4%. In contrast to Western people, 31.7% of exudative AMD cases were revealed to be PCV and 6.2% were revealed to be RAP. This discrepancy between ethnic groups should be considered in the diagnosis and treatment modality selection of Korean AMD patients.
Aged
;
Angiography
;
Choroid
;
Ethnic Groups
;
Eye
;
Female
;
Fluorescein
;
Humans
;
Hypertension
;
Incidence
;
Korea
;
Macular Degeneration
;
Male
;
Membranes
;
Photography
;
Retinaldehyde
;
Smoke
;
Smoking
;
Specialization
7.Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Multicenter Study of 65 Cases.
Jaeryung OH ; Oh Woong KWON ; Min Ho KIM ; Jong In KIM ; Ha Kyoung KIM ; Hyung Chan KIM ; Dong Heun NAM ; Kyu Hyung PARK ; Joon Hong SOHN ; Boo Sup OUM ; Seung Young YU ; Young Hee YOON ; Ill Han YOON ; Hee Sung YOON ; Jae Heung LEE ; Jeong Hee LEE ; Ji Eun LEE ; Woo Hyok CHANG ; Sung Won CHO ; Hee Seung CHIN ; Kuhl HUH ; Hyung Woo KWAK
Journal of the Korean Ophthalmological Society 2009;50(3):390-398
PURPOSE: To determine the effect of photodynamic therapy (PDT) on patients with chronic central serous chorioretinopahty (CSC). METHODS: This was a retrospective multicenter study. We collected demographic and ophthalmic data for patients with chronic CSC who were treated with PDT from 16 institutions in Korea. The best corrected visual acuity (BCVA), ophthalmoscopic finding and optical coherence tomography at baseline and follow-up visits were compared longitudinally. RESULTS: Sixty-five eyes of 65 patients were recruited. Males (51 patients, 78.5%) outnumbered females (14 patients, 21.5%). The mean age was 46.4+/-10.0 years of age (28~69). By 1 month, mean BCVA improved from 0.47 to 0.37 (logarithm of the minimum angle of resolution) (P <0.01). This BCVA increased throughout 6 months. Subretinal fluid resolved partially or completely in 89.1% of the patients. Central macular thickness (CMT) decreased from 303.4 to 168.7 micrometer. The amount of change in CMT after PDT was correlated to the female sex and prePDT CMT. At 3 months after PDT, the amount of change in BCVA was significantly related to that of change of CMT (p <0.05). Adverse events were reported in 4 cases, however, most were mild. CONCLUSIONS: PDT was effective and safe for treating chronic CSC.
Eye
;
Female
;
Follow-Up Studies
;
Humans
;
Korea
;
Male
;
Photochemotherapy
;
Retrospective Studies
;
Subretinal Fluid
;
Tomography, Optical Coherence
;
Triazenes
;
Visual Acuity
8.Efficacy of Endoscopic Resection for Small Rectal Carcinoid: A Retrospective Study.
Yu Jin KIM ; Sang Kil LEE ; Jae Hee CHEON ; Tae Ill KIM ; Yong Chan LEE ; Won Ho KIM ; Jae Bock CHUNG ; Seung Woo YI ; Semi PARK
The Korean Journal of Gastroenterology 2008;51(3):174-180
BACKGROUND/AIMS: Well differentiated rectal carcinoid tumors which are less than 1cm in diameter can be treated by endoscopic resection. We aimed to evaluate the efficacy of endoscopic resection in treating small sized rectal carcinoids. METHODS: Medical records of 30 rectal carcinoid cases treated by endoscopic resection in Yonsei University College of Medicine, Severance Hospital between January 1995 and March 2007 were reviewed retrospectively. RESULTS: Mean age was 49.7 years and male to female ratio was 1:0.88. Mean size of tumor was 6.29+/-3.06 mm and 25 out of 30 patients (83.3%) had tumors of diameter less than 10 mm. Twenty-two out of 30 patients treated by conventional polypectomy, 6 by endoscopic mucosal resection using a transparent cap (EMR-C) and 2 by endoscopic submucosal dissection (ESD). Histological examination revealed that 9 patients had resection margin positive for tumor; 7 (31.8%) were in polypectomy group, 1 (16.7%) in EMR-C group, and 1 (50%) in ESD group (p=0.868). Five patients underwent transanal excision to remove residual tumor. No residual tumor was found in additionally resected tissue. Mean follow-up duration was 19. 3 months (range 0-122), and there were no recurrence. CONCLUSIONS: Endoscopic resection is an effective method in the treatment of small rectal carcinoids. However, long-term outcome remains to be elucidated by a large scaled prospective study.
Adult
;
Aged
;
Carcinoid Tumor/pathology/*surgery/therapy
;
Demography
;
*Endoscopy, Gastrointestinal
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
*Microsurgery
;
Middle Aged
;
Rectal Neoplasms/pathology/*surgery/therapy
;
Retrospective Studies
;
Treatment Outcome
9.Prognostic outcome of patients with clinical stage I-II endometrial cancer according to bilateral salpino-oophorectomy.
Chan Hee HAN ; Si Yeon LIM ; Ill Young KOOK ; Keun Ho LEE ; Sung Eun NAMKOONG ; Jong Sup PARK ; Tae Chul PARK
Korean Journal of Obstetrics and Gynecology 2007;50(2):288-294
OBJECTIVE: The aim of this study is to verify the clinical outcome of staging surgery with and (or) without bilateral salpingo-oophorectomy (BSO) in clinical stage I-II endometrial cancer patients. METHODS: We reviewed the medical records of 178 surgically treated patients in clinical stage I-II endometrial cancer between January 1994 and December 2004. Overall survival (OS) and disease free survival (DFS) were analyzed by using data gathered from the National Statistics Office. The clinical outcome was compared between patients who underwent hysterectomy with and without BSO. RESULTS: One hundred sixty patients were in clinical stage I, and 18 patients were in clinical stage II. Most of the cases showed endometrioid (93.8%) in histology and G1 (56.1%) in differentiation. BSO was performed in 142 patients. Surgico-pathological features of two group are not different but the group without BSO were younger (40.7 vs. 55.8 years old) and less myometrial invasion than the group with BSO. After mean 39.27 months follow up, we found no difference in OS and DFS between the two groups with BSO and without BSO. No factors except stage were significantly related with OS and DFS by multivariate Cox regression analysis. The rate of pelvic and paraaortic lymph node metastasis was not different between two groups. CONCLUSION: The retrospective data in the study reveals that staging surgery with and without BSO does not affect OS and DFS in clinical stage I-II endometrial cancer patients. In limited cases, such as young women, omitting BSO can be considered carefully.
Disease-Free Survival
;
Endometrial Neoplasms*
;
Female
;
Follow-Up Studies
;
Humans
;
Hysterectomy
;
Lymph Nodes
;
Medical Records
;
Neoplasm Metastasis
;
Retrospective Studies
10.Treatment of Subtrochanteric Fractures with Compression Hip Screw.
Kee Haeng LEE ; Hyoung Min KIM ; Youn Soo KIM ; Chang Hoon JEONG ; Il Jung PARK ; Ill Seok PARK ; Chan Woong MOON
Journal of the Korean Fracture Society 2006;19(1):1-5
PURPOSE: To evaluate the effectiveness of the compression hip screw, we reviewed the clinical results of cases of femoral subtrochanteric fracture which were treated with compression hip screw. MATERIALS AND METHODS: From May 1997 to June 2004, 20 cases of femoral subtrochanteric fracture, which were treated with compression hip screw and followed up more than 12 months, were reviewed. By the Seinsheimer's classification, there were 1 case of type IIa, 4 cases of type IIb, 2 cases of type IIIa and IIIb, 4 cases of type IV and 7 cases of V. We analyzed the treatment results by bony union time, range of motion, ambulation status and complications. RESULTS: All 20 cases were gained bony union without serious complications and secondary operation. The average bony union time was 19.8 weeks. 17 of 20 cases were recovered pre-injury ambulatory status level. CONCLUSION: The compression hip screw may be effective in treatment of the femoral subtrochanteric fracture with very narrow intramedullary canal, proximal femoral deformity, comminuted fracture with large butterfly fragment, long spiral fracture with medial cortical comminution and combined intertrochanteric fracture.
Butterflies
;
Classification
;
Congenital Abnormalities
;
Femur
;
Fractures, Comminuted
;
Hip Fractures*
;
Hip*
;
Range of Motion, Articular
;
Walking

Result Analysis
Print
Save
E-mail